N-(3-methylimidazo[4,5-f]quinolin-2-yl)hydroxylamine

Names

[ CAS No. ]:
77314-23-9

[ Name ]:
N-(3-methylimidazo[4,5-f]quinolin-2-yl)hydroxylamine

[Synonym ]:
2-HYDROXYAMINO-3-METHYL-3H-IMIDAZO[4,5-F]QUINOLINE
N-Hydroxy-3-methyl-3H-imidazo(4,5-f)quinoline-2-amine
N-Hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline
n-hydroxy-3-methyl-3h-imidazo[4,5-f]quinolin-2-amine
2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline
2-Hydroxyamino-3-methylimidazo[4,5-f]quinoline
3H-Imidazo(4,5-f)quinoline-2-amine,N-hydroxy-3-methyl
1,3-Dihydro-3-methyl-2H-imidazo(4,5-f)quinolin-2-one oxime

Chemical & Physical Properties

[ Density]:
1.47g/cm3

[ Boiling Point ]:
490.3ºC at 760 mmHg

[ Melting Point ]:
>200ºC dec.

[ Molecular Formula ]:
C11H10N4O

[ Molecular Weight ]:
214.22300

[ Flash Point ]:
250.3ºC

[ Exact Mass ]:
214.08500

[ PSA ]:
62.97000

[ LogP ]:
1.99560

[ Index of Refraction ]:
1.751

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ5918500
CHEMICAL NAME :
2H-Imidazo(4,5-f)quinolin-2-one, 1,3-dihydro-3-methyl-, oxime
CAS REGISTRY NUMBER :
77314-23-9
LAST UPDATED :
199612
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C11-H10-N4-O
MOLECULAR WEIGHT :
214.25

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

MUTATION DATA

TYPE OF TEST :
DNA adduct
TEST SYSTEM :
Human Mammary gland
DOSE/DURATION :
20 umol/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 16,775,1995

Safety Information

[ HS Code ]:
2933990090

Synthetic Route

Precursor & DownStream

Precursor

  • 3-Methyl-2-nitro-3H-imidazo[4,5-F]quinoline
  • 3-methylimidazo[4,5-f]quinolin-2-amine,hydrobromide

DownStream

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • N-(3-methylimidazo[4,5-f]quinolin-2-yl)nitrous amide
  • N-(3-methylimidazo[4,5-f]quinolin-2-yl)acetamide
  • 3-({[(Benzyloxy)carbonyl]amino}methyl)bicyclo[3.1.0]hexane-3-carboxylic acid
  • 1-(2,2-difluoro-3-hydroxypropyl)-5-ethyl-1H-1,2,3-triazole-4-carbaldehyde
  • (3aS,8aR)-1,2,3,3a,8,8a-Hexahydro-5-methoxy-3a-methyl-1,8-bis(phenylmethyl)pyrrolo[2,3-b]indole
  • Phosphonic acid, [(3-methoxy-3-methyl-2-oxo-4-phenyl-1-azetidinyl)methyl]-, diethyl ester, cis-
  • 5-cyclopropyl-1-(5-hydroxypentyl)-1H-1,2,3-triazole-4-carbaldehyde
  • Benzenebutanoic acid, I+/--[[(1R,8S)-octahydro-1-[[(2-mercaptoethyl)amino]carbonyl]-10-oxo-6H-pyridazino[1,2-a][1,2]diazepin-8-yl]amino]-, (I+/-S)-
  • Ethyl 2-[(4,5-dimethoxy-2-nitrophenyl)methylene]-5-(4-fluorophenyl)-2,3-dihydro-3-oxo-7-phenyl-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate
  • 5-(propan-2-yl)-1-(pyrazin-2-yl)-1H-pyrazole-3-carboxylic acid
  • 2,5-Cyclohexadiene-1,4-dione, 2-methyl-5-(1-methylethyl)-, 1-[(2,4-dinitrophenyl)hydrazone]
  • (I(2)S)-I(2)-Amino-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2,5-dimethyl-1H-pyrrole-3-propanenitrile
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.